| Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) |
|---|
| 05/16/2007 | CN1964957A Anionic-sweetener-based ionic liquids and methods of use thereof |
| 05/16/2007 | CN1964956A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 05/15/2007 | US7217831 example compound N-Phosphonomethyl-L-Valine; particularly effective in controlling Helicoverpa spp (Heliothis, cotton budworm) in cotton |
| 05/15/2007 | US7217726 Oxazolidinon-3-ylphenyl -piperazine, -imidazolidine, and -diazepine derivatives, e.g., S)-N-[3-[3-Fluoro-4-[4-(5-nitrofuran-2-ylthiocarbonyl)piperazin-1-yl]phenyl]-2-oxooxazolidin-5-ylmethyl]thioacetamide; treating bacterial infections, particularly those that are antibiotic resistant |
| 05/15/2007 | US7217725 Prostaglandin D2 antagonist |
| 05/15/2007 | CA2236293C Intermediates for the hemisynthesis of taxanes and processes for their preparation |
| 05/10/2007 | WO2007052843A1 Heterocyclic amide compound and use thereof |
| 05/10/2007 | WO2007025709A3 Organic compounds |
| 05/10/2007 | US20070106079 Acylation, chlorination, coupling |
| 05/10/2007 | US20070106077 Synthesis of substituted heterocyclic compounds |
| 05/10/2007 | US20070105949 Intermediates for the preparation of lipoxin A4 analogs |
| 05/10/2007 | US20070105921 Process for Preparing Oxazole Intermediates |
| 05/10/2007 | US20070105892 Amidino compounds as cysteine protease inhibitors |
| 05/10/2007 | US20070105859 4-Phenylamino-benzaldoxime derivatives and uses thereof as mitogen-activated protein kinase kinase (mek) inhibitors |
| 05/09/2007 | EP1783111A1 Method for producing optically active cyclopropanecarboxylate compound |
| 05/09/2007 | EP1781630A1 Novel piperidine derivative for the treatment of depression |
| 05/09/2007 | EP1781628A2 Prodrug substituted benzoxazoles as estrogenic agents |
| 05/09/2007 | CN1960981A Non-imidazole heterocyclic compounds as histamine h3 receptor modulators |
| 05/09/2007 | CN1314673C Multidentate oxazoline ligand having chirality and its compounding product with main group metal or transition metal, synthesis method and its use |
| 05/08/2007 | US7214696 Administering compounds such as -Carboxy-2-(3,5-difluorophenyl)-benzoxazole for therapy of transthyretin amyloid disease |
| 05/08/2007 | US7214695 Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 05/08/2007 | US7214694 Controlling transforming growth facor; artificial skin; wound healing agents |
| 05/08/2007 | US7214677 Benzamide, heteroarylamide and reverse amides |
| 05/03/2007 | WO2007048595A1 Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses |
| 05/03/2007 | US20070099991 Selective rxr ligands |
| 05/03/2007 | US20070099972 Polymorphic forms of (S)-1-cyanobutan-2-yl (S)-1-(3-(3-(3-methoxy-4- (oxazol-5-yl)phenyl) ureido)phenyl) ethylcarbamate |
| 05/03/2007 | CA2627234A1 Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses |
| 05/02/2007 | EP1780197A1 5-substituted-2-phenylamino-benzamide as mek inhibitor |
| 05/02/2007 | EP1780196A2 Pyridine derivatives for use as vanilloid receptor ligands |
| 05/02/2007 | EP1778655A1 2 - { - 3 2 - (phenyl)-oxazol-4-ylmethoxyl-cyclohexylmethoxy}-propionic acid derivatives used as ppar ligands (peroxisome proliferator-activated receptors) for the treatment of hyperlipidaemie and diabetes |
| 05/02/2007 | EP1778654A1 Sulfamide derivatives and pharmaceutical composition for upregulation of lipid metabolism comprising same |
| 05/02/2007 | EP1778653A1 Biaryl heterocyclic compounds and methods of making and using the same |
| 05/02/2007 | EP1658285B1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| 05/02/2007 | EP1313716B1 Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists |
| 05/02/2007 | EP1115693B1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY |
| 05/02/2007 | CN1313146C Methods and compositions useful for inhibition of 'alpha'v'beta'5 mediated angiogenesis |
| 05/01/2007 | USRE39607 Herbicidal sulphonylamino(thio) carbonyl compounds |
| 05/01/2007 | US7211695 Trans-1,4-bis{N-[2-(4-hydroxy-3-hydroxymethylphenyl)-2-hydroxyethyl]amino}cyclohexane from aminating a dihydroxymethyl phenyl ketone with a diaminophenylene compound and a reducing agent; treating respiratory diseases, asthma, bronchitis, nervous system injury, premature labor |
| 05/01/2007 | US7211680 (5Z,7E,22E)-(1S,3R,24R)-25-phenyl-26,27-cyclo-9,10-secocholesta-5,7,10(19),22-tetraene-1,3,24-triol; treating hyperprolifierative diseases of the skin, tumor diseases and precancerous stages, auto-immune diseases, rejection reactions in the case of autologous, allogenic or xenogenic transplants, AIDS |
| 05/01/2007 | US7211674 Process for the recovery of oxazole |
| 05/01/2007 | US7211668 PNA monomer and precursor |
| 05/01/2007 | US7211591 Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredient |
| 05/01/2007 | CA2244836C Benzoheterocyclic derivatives as antidiabetic and antiobesity agents |
| 04/26/2007 | WO2007047306A1 Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors |
| 04/26/2007 | WO2006133216A3 4-substituted arylamine derivatives and their use in pharmaceutical compositions |
| 04/26/2007 | US20070093492 Pyrrolidine derivatives |
| 04/26/2007 | CA2624904A1 Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors |
| 04/25/2007 | EP1539147A4 Methods of treating microbial infections in humans and animals |
| 04/25/2007 | CN1953962A A process for the preparation of 2,2-disubstituted pyrroles |
| 04/24/2007 | US7208527 Potassium channel modulators |
| 04/24/2007 | US7208497 Substituted piperazines and diazepanes |
| 04/24/2007 | US7208450 Pesticidal (dihalopropenyl) phenylalkyl substituted benzoxazole and benzothiazole derivatives |
| 04/24/2007 | CA2420861C Method for applying polymeric lens coating |
| 04/24/2007 | CA2179584C Pharmaceutical composition containing insulin sensitivity enhancer in combination with another antidiabetic |
| 04/24/2007 | CA2154485C Pharmaceutical composition containing 5-morpholinomethyl-3-(4-chlorobenzylideneamine)-2-oxazolidinone and its use for the treatment of cns disorders |
| 04/24/2007 | CA2075173C Compounds and methods for inhibition of hiv and related viruses |
| 04/19/2007 | WO2007043401A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same |
| 04/19/2007 | WO2007043400A1 Nitrogenated aromatic heterocyclic compound and pharmaceutical composition comprising the same |
| 04/19/2007 | WO2007042816A1 Benzoxazoles useful in the treatment of inflammation |
| 04/19/2007 | WO2007017546A3 Method of obtaining tryptamine derivatives |
| 04/19/2007 | WO2007009389A3 Substituted propanamide derivatives, preparation and use thereof |
| 04/19/2007 | WO2006055837A3 Process for preparing oxazolidine derivatives |
| 04/19/2007 | US20070088061 use treating peroxysome proliferator-activated receptor gamma (PPAR gamma ) mediated diseases and conditions such as diabetes, insulin resistance; e.g. 2-(1,3-benzoxazol-2-ylamino)-3-(4-(2,3-dihydro-1,4-benzodioxin-6-ylmethoxy)phenyl)propionic acid |
| 04/19/2007 | CA2628863A1 Composition and synthesis of new reagents for inhibition of hiv replication |
| 04/19/2007 | CA2623327A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same |
| 04/19/2007 | CA2620899A1 Benzoxazoles useful in the treatment of inflammation |
| 04/18/2007 | EP1773821A2 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders |
| 04/18/2007 | EP1773786A2 Five-membered heterocycles useful as serine protease inhibitors |
| 04/18/2007 | EP1773398A2 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease |
| 04/18/2007 | EP1773348A2 Tetrapeptide analogs |
| 04/18/2007 | EP1353662B1 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
| 04/18/2007 | EP1028940B1 Process to produce oxazolidinones |
| 04/18/2007 | CN1950366A Thioether derivatives, their manufacture and use as pharmaceutical agents |
| 04/18/2007 | CN1950347A 2-aminoaryloxazole compounds as tyrosine kinase inhibitors |
| 04/18/2007 | CN1948306A Fluoroquinolone-oxazolidone derivative, its preparation method and application |
| 04/18/2007 | CN1310897C A semi-synthetic process for the preparation of N debenzoylpaclitaxel |
| 04/18/2007 | CN1310881C New 3-aryl-2-hydroxypropionic acid derivative I |
| 04/17/2007 | USRE39575 For therapy of sleep, eating and brain disorders, wakefulness promoters; Parkinson's disease, antiischemic agents, stroke, chronic fatigue syndrome; antidepressants; schizophrenia, nervous system disorders; multiple sclerosis, cognition activators |
| 04/17/2007 | US7205326 Tyrosine inhibitor inhibitors; anticancer agents |
| 04/17/2007 | US7205324 IMPDH (inosine-5'-monophosphate dehydrogenase); transplant rejection and autoimmune diseases |
| 04/11/2007 | EP1772453A1 Process to produce Oxazolidinones |
| 04/11/2007 | EP1771432A2 Non-imidazole heterocyclic compounds as histamine h3 receptor modulators |
| 04/11/2007 | EP1351938B1 Phenyl derivatives |
| 04/11/2007 | EP0950656B1 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
| 04/11/2007 | CN1944417A Five-membered-ring compound |
| 04/11/2007 | CN1943786A Ester compound and its medicinal application |
| 04/11/2007 | CN1309712C Precursor of key intermediate of AG 7088 class compound and its sythetic process |
| 04/10/2007 | US7202257 Ureas 1-substituted with a 5 member nitrogen-containing ring in turn substituted with an oxymethylphenyl group and 3-(hetero)aryl-substituted, e.g., 1-{3-tert-butyl-1-[3-(hydroxymethyl)phenyl]-1H-pyrazol-5-yl}-3-(naphthalen-1-yl)urea; used to modulate of the activation state of p38 kinase protein |
| 04/10/2007 | CA2212895C Benzylpiperidines and piperazines as muscarinic antagonists |
| 04/05/2007 | WO2007037187A1 Sulfonamide derivative having pgd2 receptor antagonistic activity |
| 04/05/2007 | WO2007037010A1 Phenoxyacetic acid derivatives and drugs using the same |
| 04/05/2007 | WO2006055184A3 Novel heterocycle derivatives useful as selective androgen receptor modulators (sarms) |
| 04/05/2007 | US20070078186 Methods for treating transthyretin amyloid diseases |
| 04/05/2007 | US20070078156 Derivatives of n-(1h-indazolyl)-and n-(1h-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (vr1) for treatment of pain |
| 04/05/2007 | CA2621310A1 Sulfonamide derivative having pgd2 receptor antagonistic activity |
| 04/04/2007 | EP1770092A1 Process for the preparation of 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl)-2,4-thiazolidinedione |
| 04/04/2007 | EP1768968A1 2-((hetero) aryl)-benzoxazole compounds and derivatives, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 04/04/2007 | EP1768967A1 Novel intermediates for linezolid and related compounds |
| 04/04/2007 | CN1942457A 1,3,5-substituted phenyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease |
| 04/04/2007 | CN1942186A Pyrrolidine compounds |